Skip to content

Does an Active Range of Motion Monitor Improve Outcomes/Decrease Cost for Patients Undergoing Total Knee Arthroplasty?

Does an Active Range of Motion Monitor Improve Outcomes and Decrease Cost for Patients Undergoing Total Knee Arthroplasty?

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05310474
Enrollment
200
Registered
2022-04-05
Start date
2022-04-30
Completion date
2023-12-31
Last updated
2022-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Knee Arthroplasty (TKA)

Brief summary

The purpose of this study is to study the efficacy of a remote range of motion monitor, the Knee Glider, alongside a patient engagement platform, Force Therapeutics, on clinical improvements and cost following primary TKA.

Detailed description

The purpose of this study is to study the efficacy of a remote range of motion monitor, the Knee Glider, alongside a patient engagement platform, Force Therapeutics, on clinical improvements and cost following primary TKA. Patients will be given the opportunity to participate, and enrolled and consented participants will be treated and followed by physicians from OSI Orthopedic & Sports Medicine. Upon consent, patients will be randomized to receive the active range of motion monitor (the knee glider) two weeks prior to surgery, near day of surgery to use postoperatively, or standard of care (no knee glider). All patients enrolled in the study will have access to Force Therapeutics, patient engagement and outcome collection system utilized by OSI Orthopedic & Sports Medicine. Enrolled subjects will be followed from the time of consent, through 6 months following surgery. Patients who are randomized into groups receiving the knee glider will receive the knee glider for up to 4 weeks following surgery, and compliance will be monitored. The hypothesis of this study is that patients who utilize an active range of motion monitor (the knee glider) will have improved clinical outcomes over patients receiving standard of care.

Interventions

DEVICEKnee Glider

The purpose of this study is to study the efficacy of a remote range of motion monitor, the Knee Glider, alongside a patient engagement platform, Force Therapeutics, on clinical improvements and cost following primary TKA.

Sponsors

OSI Orthopedics and Sports Medicine
CollaboratorUNKNOWN
Rehab 360 Knee Glider
CollaboratorUNKNOWN
Force Therapeutics
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Intervention model description

This study includes 3 arms.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Individuals who have undergone Total Knee Arthroplasty (TKA) and have agreed to participate in this study.

Exclusion criteria

* Individuals who have not undergone TKA.

Design outcomes

Primary

MeasureTime frameDescription
Baseline Patient CharacteristicsBaselineIntended to collect patient demographics, contact information, birth date, surgery date, age and other baseline demographic variables.
Knee Injury and Osteoarthritis Outcome Score (KOOS Jr.)Baseline, 2 Weeks Post Op, 6 Weeks Post Op, 12 Weeks Post Op, 6 Months Post Op,Intended to elicit people's opinions about the difficulties they experience due to problems with their knee and covers aspects of pain, functional limitations and knee-related quality of life. KOOS, JR is scored by summing the raw response (range 0-28) and then converting it to an interval score using the table provided below. The interval score ranges from 0 to 100 where 0 represents total knee disability and 100 represents perfect knee health.
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)Baseline1. The WOMAC is a disease-specific tool used for people with hip or knee OA to measure physical function, pain, and stiffness in the past 48 hours. 2. The WOMAC is a self-administered instrument containing 24 items measuring 3 subscales: physical function (17 items), pain (5 items), and stiffness (2 items). 3. Scores can be calculated for each subscale and a total score is calculated by adding all 3 subscale scores. Higher points signify higher levels of functional difficulty.
Veterans RAND 12 (VR-12)Baselinea. The Veterans RAND 12 Item Health Survey (VR-12) is a patient-reported global health measure that is used to assess a patient's overall perspective of their health.
Force Patient EngagementBaselineEngagement on the patient engagement platform including logins, exercise videos watched and patient recorded outcome measures (PROM) compliance during platform access
Range of Motion via the Knee GliderBaselineDaily Knee Flexion and Extension for the duration of utilizing the knee glider
Range of Motion (Exam / Patient Reported)Baselinea. Knee Flexion and Extension via in clinic exam or patient reported via the Force Therapeutics Platform
Daily NRS Pain (Continuous)BaselineThe NPRS is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0-10 integers) that best reflects the intensity of his/her pain
Discharge Services Utilization & Cost6 Weeks Post OpThe Discharge Services Utilization & Cost survey is intended collect patient discharge information. The survey consists of 16 questions asking about where they went for physical therapy, how much it costs, and if any adverse events resulted in admission to an Emergency Room or Urgent Care.
Knee Glider Satisfaction2 Weeks Post OpThe Knee Glider Satisfaction questionnaire is a 4 question survey asking about patient experience using the glider.
Total Joint Replacement (TJR) Satisfaction12 Weeks Post OpThe TJR Satisfaction survey intends to understand patient experience and satisfaction results with their total joint replacement procedure.

Contacts

Primary ContactJoyce Harary, BA
joyce@forcetherapeutics.com6463319165
Backup ContactBen Koerner, DO, MBA
benkoerner5@gmail.com(316)648-5158

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026